Women's Health 2023: Beyond the Annual Visit - West - December 1, 2023

Women's Health 2023: Beyond the Annual Visit - West - December 1, 2023

Live Broadcast
6.50 available credits
Information
December 01, 2023
08:00 AM - 04:00 PM PST
ReachMD Healthcare Image
Details
Presenters
Comments
  • Overview

    Designed for women's health and primary care specialties, Women’s Health 2023: Beyond the Annual Visit is a complimentary, full-day CME live broadcast featuring experts discussing the latest screening, diagnostic, and treatment guidelines to help healthcare professionals provide the best possible lifelong care for the whole female patient.

    We're excited to announce Dr. Anita Nelson, Dr. Amy Clouse, and Ms. Barbara Dehn as this year's Planning Committee and Moderators!

    Join the conversation #WH23

    Please see below for when the Live Broadcast will begin in your time zone:

    • 10 AM CT
    • 11 AM ET
    • 9 AM MT
    • 8 AM PT
  • Program Schedule*

    Time (PT) 
     
    8:00 AM – 8:05 AM 
    Welcome, Introductions, Program Announcements 

    Anita L. Nelson, MD, Barbara Dehn, NP, and Amy Clouse, MD 

    Program Co-Chairs 

    8:05 AM – 8:40 AM 

    Amy Clouse, MD 

    8:40 AM – 9:10 AM 

    Barbara Dehn, NP 

    9:10 AM – 9:55 AM 

    Anita Nelson, MD 

    9:55 AM – 10:10 AM 
    Question & Answer Session 
    10:10 AM – 10:20 AM 
    Break  
    10:20 AM – 11:15 AM 

    Jessica Ailani, MD & Dawn Buse, PhD 

    11:15 AM – 11:50 AM 

    Lee Shulman, MD, FACOG, FACMG & Kristina Deligiannidis, MD 

    11:50 AM – 12:40 PM 

    Anita Nelson, MD 

    12:40 PM - 12:55 PM 
    Question & Answer Session 
    12:55 PM – 1:25 PM 
    Break 
    1:25 PM – 2:15 PM 
    Anita Nelson, MD 
    Barbara Dehn, NP 
    2:15 PM – 2:55 PM 

    Erin Michos, MD, MHS, FAHA, FACC, FASE, FASPC 

     

    2:55 PM – 3:15 PM 
    Question & Answer Session & Closing Remarks  
  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Planning Committee:

    Amy Clouse, MD
    Associate Clinical Professor
    Sidney Kimmel Medical College, Thomas Jefferson University
    Associate Residency Director, Family Medicine Residency Program
    Jefferson – Abington Health
    Jenkintown, PA 

    Consulting Fees: Astellas 

    Barbara Dehn, RN, MS, NP, FAANP, NCMP
    Nurse Practitioner
    El Camino Women's Medical Group
    Mountain View, CA 

    No relevant relationships reported.

    Anita L. Nelson, MD
    Professor and Chair of Obstetrics & Gynecology
    Western University of Health Sciences, Pomona, CA
    Professor Emeritus, Obstetrics & Gynecology
    David Geffen School of Medicine at UCLA, Los Angeles, CA
    Clinical Professor, Obstetrics & Gynecology
    University of Southern California, Los Angeles, CA

    Consulting Fees: Agile Therapeutics, Bayer HealthCare, Mayne Pharma, Pfizer, TherapeuticsMD
    Commercial Interest Speakers Bureau: Agile Therapeutics, Bayer HealthCare, Mayne Pharma, Myovant Sciences, Organon/Merck & Co., TherapeuticsMD
    Contracted Research: Mylan Pharmaceuticals, Myovant Sciences, Organon/Merck & Co., Sagami Rubber Industries, Sebela Pharmaceuticals

    Faculty:

    Jessica Ailani, MD 
    Director, Georgetown Headache Center 
    MedStar Georgetown University Hospital 
    Washington, DC 
     
    Research: Ipsen, Parema, Satsuma 
    Consulting Fees: Abbvie, Aeon, Amgen, Axsome, Biohaven, GlaxoSmithKline, Gore, Impel, Ipsen, Lilly, Lundbeck, Merz, Miravo, Neurolief, Pfizer, Satsuma, Teva, Theranica,  
     
    Dawn C. Buse, PhD 
    Clinical Professor 
    Albert Einstein College of Medicine 
    Bronx, NY  

    No relevant relationships reported.

    Lee P. Shulman, MD, FACOG, FACMG 
    Professor, Department of Obstetrics & Gynecology
    Feinberg School of Medicine
    Northwestern University 
    Chicago, IL
     
    Consulting Fees: Alliance Pharma, Amazon, Juniper Genomics, Mayne, Shield  
    Speaker Fees: Daiichi Sankyo, Mayne, Shield 
    Other: Astellas (DSMB Chair) 
     
    Kristina Deligiannidis, MD 
    Director, Women’s Behavioral Health  
    Zucker Hillside Hospital, Northwell Health 
    New York, NY 

    Consulting Fees: Biogen, Brii Biosciences, G H Research Ireland, Gerbera Therapeutics, NextSense, Reunion Neuroscience 

    Research: Premier Healthcare, Sage Therapeutics, Woebot Health 
     
    Erin D. Michos, MD, MHS, FAHA, FACC, FASE, FASPC
    Director of Women’s Cardiovascular Health Research 
    Associate Professor of Medicine and Epidemiology, Division of Cardiology
    Johns Hopkins School of Medicine
    Co-Editor in Chief, the American Journal of Preventive Cardiology 
    Baltimore, MD

    Consulting Fees: Amgen, Amarin, Boehringer Ingelheim, Edwards Lifesciences, Esperion, Medtronic, Novartis, Novo Nordisk, and Pfizer 

    Roger Dmochowski, MD, MMHC, FACS
    Professor of Urology, Surgery, and Gynecology 
    Vanderbilt University Medical Center 
    Nashville, TN

    Consulting Fees: Urovant Sciences

    David R. Staskin, MD
    Associate Professor, Urology
    Tufts University School of Medicine 
    Boston, MA

    Consulting Fees: Astellas Pharma, Inc., Urovant Sciences
    Research: Astellas Pharma, Inc., Urovant Sciences

    Reviewers/Content Planners/Authors: 

    • Sean T. Barrett has nothing to disclose.
    • Stephen Chavez has nothing to disclose. 
    • Cindy Davidson has nothing to disclose.
    • Barry Fiedel, PhD, has nothing to disclose.
    • Samantha Keehn has nothing to disclose. 
    • Hany Ibrahim, MD, has nothing to disclose. 
    • Brian Mcdonough, MD, has nothing to disclose. 
    • Tim Person has nothing to disclose.
    • Robert Schneider, MSW, has nothing to disclose.
    • Mara Siegel has nothing to disclose.
  • Target Audience

    This course is designed to meet the educational needs of physicians, nurse practitioners, physician assistants, nurses, and certified nurse midwives in the fields of obstetrics and gynecology, primary care, family medicine, and internal medicine.

  • Accreditation and Credit Designation Statements

    In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

    Global Learning Collaborative (GLC) designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Global Learning Collaborative (GLC) designates this activity for 6.5 nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider(s)/Educational Partner(s)

    Omnia Education is the leading provider of education for women’s health professionals. Our activities are recognized nationwide for providing credible, relevant, and practical information on issues impacting the female patient. Additionally, our unique focus has transformed the CME learning environment, and our ability to help learners recognize and overcome barriers to optimal performance and optimal patient outcomes has positioned us as a leader in women’s health education.

  • Commercial Support

    This activity is supported by an independent educational grant(s) from AbbVie, Astellas, Pfizer, Inc., & Sage Therapeutics and Biogen.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Omnia Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Omnia Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited
    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.

Facebook Comments

Details
Presenters
Comments
  • Overview

    Designed for women's health and primary care specialties, Women’s Health 2023: Beyond the Annual Visit is a complimentary, full-day CME live broadcast featuring experts discussing the latest screening, diagnostic, and treatment guidelines to help healthcare professionals provide the best possible lifelong care for the whole female patient.

    We're excited to announce Dr. Anita Nelson, Dr. Amy Clouse, and Ms. Barbara Dehn as this year's Planning Committee and Moderators!

    Join the conversation #WH23

    Please see below for when the Live Broadcast will begin in your time zone:

    • 10 AM CT
    • 11 AM ET
    • 9 AM MT
    • 8 AM PT
  • Program Schedule*

    Time (PT) 
     
    8:00 AM – 8:05 AM 
    Welcome, Introductions, Program Announcements 

    Anita L. Nelson, MD, Barbara Dehn, NP, and Amy Clouse, MD 

    Program Co-Chairs 

    8:05 AM – 8:40 AM 

    Amy Clouse, MD 

    8:40 AM – 9:10 AM 

    Barbara Dehn, NP 

    9:10 AM – 9:55 AM 

    Anita Nelson, MD 

    9:55 AM – 10:10 AM 
    Question & Answer Session 
    10:10 AM – 10:20 AM 
    Break  
    10:20 AM – 11:15 AM 

    Jessica Ailani, MD & Dawn Buse, PhD 

    11:15 AM – 11:50 AM 

    Lee Shulman, MD, FACOG, FACMG & Kristina Deligiannidis, MD 

    11:50 AM – 12:40 PM 

    Anita Nelson, MD 

    12:40 PM - 12:55 PM 
    Question & Answer Session 
    12:55 PM – 1:25 PM 
    Break 
    1:25 PM – 2:15 PM 
    Anita Nelson, MD 
    Barbara Dehn, NP 
    2:15 PM – 2:55 PM 

    Erin Michos, MD, MHS, FAHA, FACC, FASE, FASPC 

     

    2:55 PM – 3:15 PM 
    Question & Answer Session & Closing Remarks  
  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Planning Committee:

    Amy Clouse, MD
    Associate Clinical Professor
    Sidney Kimmel Medical College, Thomas Jefferson University
    Associate Residency Director, Family Medicine Residency Program
    Jefferson – Abington Health
    Jenkintown, PA 

    Consulting Fees: Astellas 

    Barbara Dehn, RN, MS, NP, FAANP, NCMP
    Nurse Practitioner
    El Camino Women's Medical Group
    Mountain View, CA 

    No relevant relationships reported.

    Anita L. Nelson, MD
    Professor and Chair of Obstetrics & Gynecology
    Western University of Health Sciences, Pomona, CA
    Professor Emeritus, Obstetrics & Gynecology
    David Geffen School of Medicine at UCLA, Los Angeles, CA
    Clinical Professor, Obstetrics & Gynecology
    University of Southern California, Los Angeles, CA

    Consulting Fees: Agile Therapeutics, Bayer HealthCare, Mayne Pharma, Pfizer, TherapeuticsMD
    Commercial Interest Speakers Bureau: Agile Therapeutics, Bayer HealthCare, Mayne Pharma, Myovant Sciences, Organon/Merck & Co., TherapeuticsMD
    Contracted Research: Mylan Pharmaceuticals, Myovant Sciences, Organon/Merck & Co., Sagami Rubber Industries, Sebela Pharmaceuticals

    Faculty:

    Jessica Ailani, MD 
    Director, Georgetown Headache Center 
    MedStar Georgetown University Hospital 
    Washington, DC 
     
    Research: Ipsen, Parema, Satsuma 
    Consulting Fees: Abbvie, Aeon, Amgen, Axsome, Biohaven, GlaxoSmithKline, Gore, Impel, Ipsen, Lilly, Lundbeck, Merz, Miravo, Neurolief, Pfizer, Satsuma, Teva, Theranica,  
     
    Dawn C. Buse, PhD 
    Clinical Professor 
    Albert Einstein College of Medicine 
    Bronx, NY  

    No relevant relationships reported.

    Lee P. Shulman, MD, FACOG, FACMG 
    Professor, Department of Obstetrics & Gynecology
    Feinberg School of Medicine
    Northwestern University 
    Chicago, IL
     
    Consulting Fees: Alliance Pharma, Amazon, Juniper Genomics, Mayne, Shield  
    Speaker Fees: Daiichi Sankyo, Mayne, Shield 
    Other: Astellas (DSMB Chair) 
     
    Kristina Deligiannidis, MD 
    Director, Women’s Behavioral Health  
    Zucker Hillside Hospital, Northwell Health 
    New York, NY 

    Consulting Fees: Biogen, Brii Biosciences, G H Research Ireland, Gerbera Therapeutics, NextSense, Reunion Neuroscience 

    Research: Premier Healthcare, Sage Therapeutics, Woebot Health 
     
    Erin D. Michos, MD, MHS, FAHA, FACC, FASE, FASPC
    Director of Women’s Cardiovascular Health Research 
    Associate Professor of Medicine and Epidemiology, Division of Cardiology
    Johns Hopkins School of Medicine
    Co-Editor in Chief, the American Journal of Preventive Cardiology 
    Baltimore, MD

    Consulting Fees: Amgen, Amarin, Boehringer Ingelheim, Edwards Lifesciences, Esperion, Medtronic, Novartis, Novo Nordisk, and Pfizer 

    Roger Dmochowski, MD, MMHC, FACS
    Professor of Urology, Surgery, and Gynecology 
    Vanderbilt University Medical Center 
    Nashville, TN

    Consulting Fees: Urovant Sciences

    David R. Staskin, MD
    Associate Professor, Urology
    Tufts University School of Medicine 
    Boston, MA

    Consulting Fees: Astellas Pharma, Inc., Urovant Sciences
    Research: Astellas Pharma, Inc., Urovant Sciences

    Reviewers/Content Planners/Authors: 

    • Sean T. Barrett has nothing to disclose.
    • Stephen Chavez has nothing to disclose. 
    • Cindy Davidson has nothing to disclose.
    • Barry Fiedel, PhD, has nothing to disclose.
    • Samantha Keehn has nothing to disclose. 
    • Hany Ibrahim, MD, has nothing to disclose. 
    • Brian Mcdonough, MD, has nothing to disclose. 
    • Tim Person has nothing to disclose.
    • Robert Schneider, MSW, has nothing to disclose.
    • Mara Siegel has nothing to disclose.
  • Target Audience

    This course is designed to meet the educational needs of physicians, nurse practitioners, physician assistants, nurses, and certified nurse midwives in the fields of obstetrics and gynecology, primary care, family medicine, and internal medicine.

  • Accreditation and Credit Designation Statements

    In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

    Global Learning Collaborative (GLC) designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Global Learning Collaborative (GLC) designates this activity for 6.5 nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider(s)/Educational Partner(s)

    Omnia Education is the leading provider of education for women’s health professionals. Our activities are recognized nationwide for providing credible, relevant, and practical information on issues impacting the female patient. Additionally, our unique focus has transformed the CME learning environment, and our ability to help learners recognize and overcome barriers to optimal performance and optimal patient outcomes has positioned us as a leader in women’s health education.

  • Commercial Support

    This activity is supported by an independent educational grant(s) from AbbVie, Astellas, Pfizer, Inc., & Sage Therapeutics and Biogen.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Omnia Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Omnia Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited
    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.

Facebook Comments

Register

We’re glad to see you’re enjoying Omnia Education…
but how about a more personalized experience?

Register for free